Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
contract manufacturing
Manufacturing
BIO survey finds sudden CDMO decoupling could harm patients
Respondents to a recent BIO survey indicated that millions of patients could be harmed by a biosecurity crackdown that's gaining steam in D.C.
Angus Liu
May 9, 2024 10:00am
BIO survey to elucidate US biopharma's reliance on Chinese CDMOs
May 1, 2024 11:00am
Novartis reviews ties to China amid US biosecurity crackdown
Apr 23, 2024 11:07am
FTC to review Novo Holdings' Catalent buyout for 30 more days
Apr 8, 2024 11:58am
Merck KGaA's MilliporeSigma makes €300M pledge at new Korea site
Mar 21, 2024 1:22pm
IFF is selling off its pharma solutions business for $2.85B
Mar 19, 2024 10:40am